These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33738351)

  • 1. Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock.
    Imaoka S; Kainuma S; Toda K; Miyagawa S; Yoshioka D; Kawamura T; Kawamura A; Kashiyama N; Nakamoto K; Takeda Y; Sakata Y; Sawa Y
    Circ Rep; 2021 Mar; 3(3):178-181. PubMed ID: 33738351
    [No Abstract]   [Full Text] [Related]  

  • 2. Left Impella®-device as bridge from cardiogenic shock with acute, severe mitral regurgitation to MitraClip®-procedure: a new option for critically ill patients.
    Vandenbriele C; Balthazar T; Wilson J; Adriaenssens T; Davies S; Droogne W; Dubois C; Caetano AF; Goetschalckx K; Jacobs S; Janssens S; Ledot S; Meyns B; Soliman-Aboumarie H; Verbrugghe P; Price S
    Eur Heart J Acute Cardiovasc Care; 2021 May; 10(4):415-421. PubMed ID: 33620436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bail-Out Use of Impella CP as a Bridge to TAVI in a Cardiogenic Shock Patient: The "Pump-Rewiring" Technique.
    Burzotta F; Nerla R; Trani C
    J Invasive Cardiol; 2016 Jan; 28(1):E1-5. PubMed ID: 26716594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment of Cardiogenic Shock Due to Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction and Acute Mitral Regurgitation by Impella CP.
    Benak A; Sramko M; Janek B; Zelizko M; Kautzner J
    Cureus; 2022 Mar; 14(3):e23168. PubMed ID: 35433143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
    Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
    Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
    Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
    J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous left ventricular assist support is associated with less pulmonary congestion and lower rate of pneumonia in patients with cardiogenic shock.
    Haberkorn S; Uwarow A; Haurand J; Jung C; Kelm M; Westenfeld R; Horn P
    Open Heart; 2020 Nov; 7(2):. PubMed ID: 33132209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impella CP use in patients with non-ischaemic cardiogenic shock.
    Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock.
    Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A
    J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry.
    Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK
    J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study.
    Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E;
    Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escalation from impella 5.5 to ECPELLA support as a bridge to mitral valve surgery in a patient with degenerative mitral regurgitation.
    Gregory V; Grunfeld M; Kanwal A; Bali AD; Pan S; Spielvogel D; Kai M; Ohira S
    Perfusion; 2023 Jun; ():2676591231186725. PubMed ID: 37354131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Impella 5.5 on Preexisting Functional Mitral Regurgitation in Patients with Heart Failure-Related Cardiogenic Shock.
    Kataria R; Khalil A; Coglianese E; Crowley J; Silverman MG; Shelton K; Michel E; D'Alessandro D; Ton VK
    Struct Heart; 2022 Aug; 6(4):100072. PubMed ID: 37288332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impella in Takotsubo syndrome complicated by left ventricular outflow tract obstruction and severe mitral regurgitation.
    Attisano T; Silverio A; Prota C; Briguori C; Galasso G; Citro R
    ESC Heart Fail; 2020 Feb; 7(1):306-310. PubMed ID: 31898420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
    den Uil CA; Akin S; Jewbali LS; Dos Reis Miranda D; Brugts JJ; Constantinescu AA; Kappetein AP; Caliskan K
    Eur J Cardiothorac Surg; 2017 Jul; 52(1):14-25. PubMed ID: 28472406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Ventricular Assist Devices: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(2):1-97. PubMed ID: 28232854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "TIDE"-Algorithm for the Weaning of Patients With Cardiogenic Shock and Temporarily Mechanical Left Ventricular Support With Impella Devices. A Cardiovascular Physiology-Based Approach.
    Tschöpe C; Spillmann F; Potapov E; Faragli A; Rapis K; Nelki V; Post H; Schmidt G; Alogna A
    Front Cardiovasc Med; 2021; 8():563484. PubMed ID: 33681302
    [No Abstract]   [Full Text] [Related]  

  • 19. Afterload mismatch after transcatheter mitral valve repair with MitraClip for degenerative mitral regurgitation in acute cardiogenic shock.
    Tang GHL; Cohen M; Dutta T; Undemir C
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E168-E171. PubMed ID: 28303686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: management of refractory cardiogenic shock with Impella 5.5 in patients with transcatheter aortic valves.
    Harada R; George TJ; Schaffer J; Kabra N; Rawitscher D; Afzal A
    Eur Heart J Case Rep; 2023 Aug; 7(8):ytad381. PubMed ID: 37637091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.